PFO and stroke: what are the data?
LR Wechsler - Cardiology in Review, 2008 - journals.lww.com
Patent foramen ovale (PFO) is a frequent finding on echocardiography and occurs in over
25% of the population. In young patients with cryptogenic stroke, the frequency is much …
25% of the population. In young patients with cryptogenic stroke, the frequency is much …
Overview of the 2007 Food and Drug Administration Circulatory System Devices Panel meeting on patent foramen ovale closure devices
TLP Slottow, DH Steinberg, R Waksman - Circulation, 2007 - Am Heart Assoc
Patent foramen ovales (PFOs) are common congenital cardiac defects that are more
prevalent among patients experiencing cryptogenic stroke than among those with strokes of …
prevalent among patients experiencing cryptogenic stroke than among those with strokes of …
[HTML][HTML] Patent foramen ovale closure: state of the art
JP Giblett, LK Williams, S Kyranis… - Interventional …, 2020 - ncbi.nlm.nih.gov
Patent foramen ovale (PFO) is a common abnormality affecting between 20% and 34% of
the adult population. For most people, it is a benign finding; however, in some people, the …
the adult population. For most people, it is a benign finding; however, in some people, the …
Long-term outcomes of patent foramen ovale closure or medical therapy after stroke
JL Saver, JD Carroll, DE Thaler… - … England Journal of …, 2017 - Mass Medical Soc
Background Whether closure of a patent foramen ovale reduces the risk of recurrence of
ischemic stroke in patients who have had a cryptogenic ischemic stroke is unknown …
ischemic stroke in patients who have had a cryptogenic ischemic stroke is unknown …
Morphology of the patent foramen ovale in asymptomatic versus symptomatic (stroke or transient ischemic attack) patients
SS Goel, EM Tuzcu, MH Shishehbor… - The American journal of …, 2009 - Elsevier
The clinical implications of patent foramen ovale (PFO) morphology are still debated.
Quantitative analysis by transesophageal echocardiography (TEE) is helpful in …
Quantitative analysis by transesophageal echocardiography (TEE) is helpful in …
Patent foramen ovale closure versus medical therapy in cases with cryptogenic stroke, meta-analysis of randomized controlled trials
E Abo-Salem, B Chaitman, T Helmy, EA Boakye… - Journal of …, 2018 - Springer
Background PFO is more common in cases with cryptogenic stroke compared to cases with
no stroke or stroke of identified etiology. Several randomized controlled trials (RCTs) …
no stroke or stroke of identified etiology. Several randomized controlled trials (RCTs) …
Prevention of stroke recurrence with presumed paradoxical embolism
J Bogousslavsky, G Devuyst, M Nendaz… - Journal of …, 1997 - Springer
Paradoxical cerebral embolism (PCE) through a patent foramen ovale (PFO) should be
considered as a cause of ischemic stroke, particularly in young patients without an altenative …
considered as a cause of ischemic stroke, particularly in young patients without an altenative …
Patent foramen ovale closure in the management of cryptogenic stroke: a review of current literature and guideline statements
AM Elzanaty, N Patel, E Sabbagh… - … medical research and …, 2021 - Taylor & Francis
Objective The management recommendations for patent foramen ovale (PFO) closure in
cryptogenic stroke are rapidly evolving. The data has expanded recently with four major …
cryptogenic stroke are rapidly evolving. The data has expanded recently with four major …
Patent foramen ovale: a comprehensive review
MK Teshome, K Najib, CC Nwagbara… - Current problems in …, 2020 - Elsevier
Foramen ovale is an embryonic defect in the interatrial septum which allows passage of
oxygenated blood from the right atrium to the left atrium. 1, 2 In about 75% of the population …
oxygenated blood from the right atrium to the left atrium. 1, 2 In about 75% of the population …
Long-term outcome of transcatheter patent foramen ovale closure in patients with paradoxical embolism
A Cifarelli, C Musto, A Parma, C Pandolfi… - International journal of …, 2010 - Elsevier
BACKGROUND: Optimal management of patients with PFO and paradoxical embolic events
is still debated. Moreover, data from long-term studies on large patient populations are …
is still debated. Moreover, data from long-term studies on large patient populations are …